The global wilms tumor protein market is anticipated to grow at a significant CAGR of 2.1% during the forecast period. Wilms' tumor protein is a protein that is encoded by the WT1 gene on chromosome 11p in humans. The wilms tumor protein market is growing due to the rising prevalence of cancer cases globally. According to the World Cancer Research Fund, 18.1 million cancer cases were registered globally in 2020 and 10 million deaths were reported due to the cancer. The wilms tumor protein plays a critical role in transcriptional and post-transcriptional regulation, has been reported as an oncogene, and its expression is elevated in multiple types of human tumors. Recent researches had shown that the increased expression of wilms tumor protein is also closely related to chemo-resistance. Thus, with the rising prevalence of cancer cases globally, the demand for wilms tumor protein will also rise significantly during the forecast period. This report further analyses all the factors that are directly or indirectly impacting the global wilms tumor protein market.

Impact of COVID-19 Pandemic on Global Wilms tumor protein market

The cancer treatments likes chemotherapy, and immune suppressants were postponed during the initial period of COVID-19 pandemic as most of the hospital beds were reserved for the COVID-19 patients. This had critically reduced the demand for wilms tumor protein. As the pandemic situation got normalised, the demand had bounced back to normal as the backlog treatments were performed in the hospitals. This report will further, provides an in-depth analysis of the impact of COVID-19 on the global wilms tumor protein market.

Segmental Outlook 

The global wilms tumor protein market is segmented based on the type and distribution channel. Based on the type, the market is segmented into elatipepimut-S, galinpepimut-S, GSK-2130579A, INO-5401, OCV-501, and others. Amongst these types, galinpepimut-S segment is anticipated to propel the growth of the market over the forecast period. Based on the distribution channel, the market is sub-segmented into hospitals and clinics. Hospitals is the major distribution channel in the global wilms tumor protein market. The above-mentioned segments can also be customized as per the requirements.

Global Wilms Tumor Protein Market Share by Type, 2022 (%)

The Galinpepimut-S is Anticipated to Hold a Prominent Share in the Global Wilms Tumor Protein Market

The galinpepimut-S segment is anticipated to hold the prominent share in the global Wilms tumor protein market. Galinpepimut-S is a cancer peptide vaccine that is developed by Bristol-Myers Squibb, Memorial Sloan-Kettering Cancer Centre, Merck Sharp & Dohme Corp., and Sellas Life Sciences Group. This is used for the treatment of various haematological malignancies and solid tumor that includes acute myeloid leukemia, fallopian tube cancer, myeloma, and ovarian cancer. When galinpepimut-S is given to patients, the immune response induced by galinpepimut-S possesses the potential to identify any eliminate cancer cell and provides on-going support to the immune system. This helps to target and eliminate the recurring disease and residual cancer cells. These advantage of galinpepimut-S over other drug types to treat cancer patients is boosting the market growth. 

Hospitals are the Major Distribution Channel in the Global Wilms Tumor Protein Market 

Hospitals are the major distribution channel in the global wilms tumor protein market as such drugs are only consumed after the prescription of doctors and hospitals are the major source of cancer diagnostics and treatment as compared to clinics. However, the clinics segment is expected to grow with highest CAGR during the forecast period as the people are now preferring for more personalised treatment options than earlier. 

Regional Outlooks

The global wilms tumor protein market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East & Africa, and Latin America).  The market can also be analyzed for particular region or country level as per the requirement. 

Global Wilms Tumor Protein Market Growth, by Region 2022-2028

The North-American Region is Anticipated to Hold the Major Share in the Global Wilms Tumor Protein Market

The North-American region is anticipated to hold the major share in the global wilms tumor protein market. This is due to the increasing research and development activities in the healthcare sector as well as the early adoption of advanced treatment in this region. Additionally, the increased prevalence of cancer patient in this region is boosting the growth of the market. According to the WHO, 2.5 million new cancer cases were registered in this region during 2020 and 699.2 thousand people had died due to cancer during same year. Lung cancer is the second most prevalent type of cancer in the region in which wilms tumor protein is used as an effective treatment. Such factors are expected to fuel the growth of the wilms tumor protein market in the North America during the forecast period.

Market Players Outlook

The major companies serving the global wilms tumor protein market include GlaxoSmithKline Plc., Inovio Pharmaceuticals, Otsuka Holdings Co. Ltd., Sellas, Sumitomo Dainippos Pharma Co. Ltd., and many more. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches for the advancement of the drug, to stay competitive in the market. For instance, in March 2019, According to NCBI, G-quadruplex forming region within WT1 promoter is selectively targeted by daunorubicin and mitoxantrone and considered to be a possible mechanism for anti-leukemia effect of drugs.

The Report Covers

• Market value data analysis of 2022 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global wilms tumor protein market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.